Want to join the conversation?
$STJ announced that 5-year results from the landmark FAME trial have confirmed long-term benefits of FFR in guiding PCI over angiography alone. Analysis of the study’s follow up data confirms that in patients with multi-vessel CAD, FFR-guided PCI can contribute to reductions in all-cause & cardiac mortality and overall use of healthcare resources.
Still in yesterday’s $PZZA shock. I thought everyone had more pizza this football season!!
$TSLA stock downgraded to sell from hold by brokerage firm CFRA Research. However, the firm lifted the price target by $35 to $240.
$LB shares have plummeted after a disappointing quarter.